Cancer Therapeutic Targets and Drug Design
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 4086
Special Issue Editor
Special Issue Information
Dear Colleagues,
Targeted therapy has dramatically improved the survival outcomes of many cancers. However, most cancer types currently lack effective targeted therapeutic options, and even the cancers where first-line targeted therapies are available, the prevalence of treatment resistance and disease progression is a continuous challenge. Therefore, the discovery of novel cancer targets and targeting agents, particularly in aggressive and untreatable cancers, is a high priority.
This Special Issue explores the recent advances in new cancer therapeutic targets and drug design against those targets. This Special Issue welcomes original research or review papers demonstrating the discovery and validation of cancer therapeutic targets in vitro and in vivo and novel design strategies for small molecules, biologics, biosimilars, and other targeting agents. Original research articles should be supported by sufficient data or evidence.
Dr. Abhay K. Singh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- target discovery/identification
- target validation
- structure-based drug design
- high-throughput screening
- computer-aided drug design
- biologics
- monoclonal antibodies
- small molecules
- animal models
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
